Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study.

ABSTRACT:

SUBMITTER: Alderuccio JP 

PROVIDER: S-EPMC9631657 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature